
This Drug Just SHATTERED Weight Loss Records—Here's What It Means
A new GLP-1 drug shows promise for improving metabolic health and treating obesity-related diseases like liver disease. camacho9999/Getty Images A new weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. The drug, which stimulates GLP-1 and glucagon receptors, led to a 16.6% drop in body weight. Survodutide also reduced waist circumference, an indicator of metabolic health. Experts hope the drug will be useful for both obesity and liver disease; howeve




















































































































































































































































































































%20SOURCE%20Kobo-Higher%20Dose-Netvue.jpg)








